Go to content | Go to menu | Go to search
Close
You are about to leave Zentiva.com
The link you are about to open is not maintained by Zentiva and may potentially be unsafe.
December 22, 2021 / 2021
Zentiva opens vaccination site for employees and their families at its Prague plant
October 12, 2021 / 2021
November 3, 2021 / 2021
September 24, 2021 / 2021
September 16, 2021 / 2021
October 25, 2019 / 2019
Zentiva Acquires Central and Eastern European Business of Alvogen
April 1, 2019 / 2019
Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
September 11, 2019 / 2019
Zentiva enhances its global manufacturing footprint by signing an agreement to acquire manufacturing site in Ankleshwar, India
March 13, 2019 / 2019
Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma.
May 31, 2019 / 2019
Zentiva announces completion of Solacium Pharma acquisition
November 23, 2018 / 2018
Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe.
October 1, 2018 / 2018
oday marks generics manufacturer Zentiva’s first day as an independent organization, following completion of the company’s previously announced divestment from Sanofi.
June 28, 2018 / 2018
Sanofi and Advent International (“Advent”) have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion (enterprise value).
![]() |
|
|
![]() |
Pantone |
2727 |
![]() |
Pantone |
339 |
![]() |
Ines WindischHead of Communications, |